- Donald Trump discusses the AI leadership race with China and challenges unnamed states regarding AI regulation efforts.
- The US administration rejected a proposed FDA-style central AI regulator while acknowledging the need to compete with China in the AI race.
Ro Khanna compared his AI regulatory proposal to the FDA model.
2 reports, 1 independent
Updated Sep 24
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Ro Khanna compared his AI regulatory proposal to the FDA model.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- FDA policy proposal affects the operations of AI, Inc.
- Congress introduced AI legislation, CMS expanded value-based models, FDA built AI infrastructure, and FTC rescinded a health data breach policy.
- The FDA and Department of Health & Human Services are currently collaborating to regulate and shape the use of artificial intelligence in healthcare.
- FDA is willing to review updated submissions, while biotech hubs leverage AI to ease clinical development bottlenecks.